New perspectives of basic aspirin-induced asthma therapy

H. V. Evsyukova (St Petersburg, Russia)

Source: Annual Congress 2003 - Non-steroidal drugs in the treatment of respiratory diseases
Session: Non-steroidal drugs in the treatment of respiratory diseases
Session type: Thematic Poster Session
Number: 723
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. V. Evsyukova (St Petersburg, Russia). New perspectives of basic aspirin-induced asthma therapy. Eur Respir J 2003; 22: Suppl. 45, 723

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
New frontiers in the management of asthma
Source: International Congress 2017 – State of the art session: "Paediatric"
Year: 2017


IgE-mediated asthma: New revelations and future insights
Source: International Congress 2015 – IgE-mediated asthma: New revelations and future insights
Year: 2015


New treatments in severe paediatric asthma
Source: International Congress 2017 – PG7 Paediatric asthma
Year: 2017


New aspects of COPD ethiopathogenesis
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008

New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012


Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives
Source: Eur Respir Rev 2015; 24: 594-601
Year: 2015



Update on basic research on airway inflammation in asthma
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012


New drugs for severe asthma – what should we target and how?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014


The basic science behind asthma biologics
Source: International Congress 2018 – New biologics for asthma: which patients, which agents, which results, at what cost?
Year: 2018


Principles of antileucotrien therapy at allergic rhinitis and chronicle adenoiditis
Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management
Year: 2010


New instrument of mild asthma management
Source: Annual Congress 2010 - Medical education
Year: 2010


Do we need new therapies for noneosinophilic asthma?
Source: Annual Congress 2004 - Noneosinophilic asthma
Year: 2004

New genetics and epigenetics insights in paediatric asthma
Source: International Congress 2017 – Omics in paediatric asthma and beyond
Year: 2017


Recommended new therapies for severe asthma and the future
Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop
Year: 2014




Biologic therapies in paediatric severe asthma
Source: ERS webinar 2020: Biologic therapies in paediatric severe asthma
Year: 2020


Recommendations of new therapies for severe asthma and the future
Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma
Year: 2013


Current opinion: Pharmacological approaches in asthma and COPD
Source: Breathe 2009; 6: 24-35
Year: 2009

New targets for drug development in asthma
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008